154 related articles for article (PubMed ID: 37749067)
1. Immune thrombotic thrombocytopenic purpura in patients over 60 years of age: Diagnostic pitfalls and treatment strategy.
Lester W
Br J Haematol; 2023 Dec; 203(5):704-705. PubMed ID: 37749067
[TBL] [Abstract][Full Text] [Related]
2. Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT).
Gómez-Seguí I; Francés Aracil E; Mingot-Castellano ME; Vara Pampliega M; Goterris Viciedo R; García Candel F; Pascual Izquierdo C; Del Río Garma J; Guerra Domínguez L; Vicuña Andrés I; Garcia-Arroba Peinado J; Zalba Marcos S; Vidan Estévez JM; González Arias E; Campuzano Saavedra V; García Gala JM; Ortega Sanchez S; Martínez Nieto J; Pardo Gambarte L; Solé Rodríguez M; Fernández-Docampo M; Avila Idrovo LF; Hernández L; Cid J; de la Rubia Comos J;
Br J Haematol; 2023 Dec; 203(5):860-871. PubMed ID: 37723363
[TBL] [Abstract][Full Text] [Related]
3. Spanish registry of thrombotic thrombocytopenic purpura (REPTT): Data evidence and new developments.
Mingot-Castellano ME; Izquierdo CP; Del Rio Garma J
Transfus Apher Sci; 2023 Jun; 62(3):103725. PubMed ID: 37202322
[TBL] [Abstract][Full Text] [Related]
4. Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores.
Baysal M; Hindilerden F; Ümit EG; Demir AM; Keklik Karadağ F; Saydam G; Akpınar S; Turgut B; Özkocaman V; Özkalemkaş F; Çiftçiler R; Özlü C; Demircioğlu S; İpek Y; Diz Küçükkaya R
Turk J Haematol; 2023 Dec; 40(4):251-257. PubMed ID: 37791641
[TBL] [Abstract][Full Text] [Related]
5. Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura.
Pascual-Izquierdo C; Del Rio-Garma J; de la Rubia J; Viejo A; Mingot E; Cid J; Solanich X; Fernández-Sojo J; Martín-Sánchez J; Hernández L; García-Gala JM; Alonso N; González V; Oliva A; Gómez-Seguí I; Goterris R; Guerra L; García-Candel F; Fernández-Docampo M; Antelo ML; Salgado-Barreira Á; Salinas R;
J Clin Apher; 2021 Aug; 36(4):563-573. PubMed ID: 33780553
[TBL] [Abstract][Full Text] [Related]
6. Paediatric patients with suspected immune thrombotic thrombocytopenic purpura also experience treatment delays.
Soares Ferreira Junior A; Pinheiro Maux Lessa M; Boyle SH; Sanborn K; Kuchibhatla M; Onwuemene OA
Br J Haematol; 2024 Apr; 204(4):1545-1548. PubMed ID: 38176420
[No Abstract] [Full Text] [Related]
7. The standard of care for immune thrombotic thrombocytopenic purpura today.
Zheng XL
J Thromb Haemost; 2021 Aug; 19(8):1864-1871. PubMed ID: 34060225
[TBL] [Abstract][Full Text] [Related]
8. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.
Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A;
Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an Asian woman: a case report.
Ge H; Shi Z; Zheng Z; Zhu Q; Hong L; Zhang Y; Shen J; Deng S
J Int Med Res; 2022 Mar; 50(3):3000605221085127. PubMed ID: 35352601
[TBL] [Abstract][Full Text] [Related]
10. Management of immune thrombotic thrombocytopenic purpura with caplacizumab: a Canadian, single-centre, real-world experience.
Tse B; Buchholz M; Pavenski K
Platelets; 2023 Dec; 34(1):2157807. PubMed ID: 36636834
[TBL] [Abstract][Full Text] [Related]
11. Atypical presentations of thrombotic thrombocytopenic purpura: a diagnostic role for ADAMTS13.
Kalish Y; Rottenstreich A; Rund D; Hochberg-Klein S
J Thromb Thrombolysis; 2016 Aug; 42(2):155-60. PubMed ID: 26867546
[TBL] [Abstract][Full Text] [Related]
12. Immune-Thrombotic Thrombocytopenic Purpura is a Rare Cause of Ischemic Stroke in Young Adults: Case Reports and Literature Review.
Tomich C; Debruxelles S; Delmas Y; Sagnier S; Poli M; Olindo S; Renou P; Rouanet F; Sibon I
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3163-3171. PubMed ID: 30217637
[TBL] [Abstract][Full Text] [Related]
13. Plasma cell-directed therapy strategies in immune-mediated thrombotic thrombocytopenic purpura (iTTP).
Patır P; Önkibar N; Subari S; Eşkazan AE
Transfusion; 2024 Mar; 64(3):536-545. PubMed ID: 38235916
[No Abstract] [Full Text] [Related]
14. Congenital ADAMTS13 deficiency: a rare mimicker of immune thrombocytopenic purpura.
Quintero V; Garcia-Pose A; Barrios-Tascon A; Pacheco-Cumani M
J Pediatr Hematol Oncol; 2014 Nov; 36(8):653-5. PubMed ID: 24942015
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of diagnosis, treatment, and management for immune thrombotic thrombocytopenic purpura: Are we still peering through the looking glass?
Raval JS; Rollins-Raval MA; Mazepa MA; Park YA
J Clin Apher; 2020 Jun; 35(3):236-237. PubMed ID: 32449953
[No Abstract] [Full Text] [Related]
16. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.
Mariotte E; Azoulay E; Galicier L; Rondeau E; Zouiti F; Boisseau P; Poullin P; de Maistre E; Provôt F; Delmas Y; Perez P; Benhamou Y; Stepanian A; Coppo P; Veyradier A;
Lancet Haematol; 2016 May; 3(5):e237-45. PubMed ID: 27132698
[TBL] [Abstract][Full Text] [Related]
17. [Endothelial dysfunction in thrombotic thrombocytopenic purpura: therapeutic perspectives].
Prevel R; Roubaud-Baudron C; Tellier E; Le Besnerais M; Kaplanski G; Veyradier A; Benhamou Y; Coppo P;
Rev Med Interne; 2021 Mar; 42(3):202-209. PubMed ID: 33455838
[TBL] [Abstract][Full Text] [Related]
18. Medical consult: aHUS, TTP? How to distinguish and what to do.
Story CM; Gerber GF; Chaturvedi S
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):745-753. PubMed ID: 38066937
[TBL] [Abstract][Full Text] [Related]
19. Paradigm shift of childhood thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency.
Yagi H; Matsumoto M; Fujimura Y
Presse Med; 2012 Mar; 41(3 Pt 2):e137-55. PubMed ID: 22264931
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD20 therapeutic options in immune-mediated thrombotic thrombocytopenic purpura.
Maitta RW
Br J Haematol; 2022 Jul; 198(2):225-226. PubMed ID: 35472189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
